AptaBio Therapeutics (Korea) Price on September 26, 2024

293780 Stock   6,590  310.00  4.94%   
If you're considering investing in AptaBio Stock, it is important to understand the factors that can impact its price. As of today, the current price of AptaBio Therapeutics stands at 6,590, as last reported on the 26th of November, with the highest price reaching 6,910 and the lowest price hitting 6,300 during the day. AptaBio Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0891, which signifies that the company had a -0.0891% return per unit of risk over the last 3 months. AptaBio Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm AptaBio Therapeutics' Standard Deviation of 4.15, mean deviation of 3.11, and Risk Adjusted Performance of (0.07) to double-check the risk estimate we provide.
  
AptaBio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0891

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns293780

Estimated Market Risk

 4.14
  actual daily
36
64% of assets are more volatile

Expected Return

 -0.37
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.09
  actual daily
0
Most of other assets perform better
Based on monthly moving average AptaBio Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AptaBio Therapeutics by adding AptaBio Therapeutics to a well-diversified portfolio.

AptaBio Therapeutics Valuation on September 26, 2024

It is possible to determine the worth of AptaBio Therapeutics on a given historical date. On September 26, 2024 AptaBio was worth 7980.0 at the beginning of the trading date compared to the closed value of 8150.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of AptaBio Therapeutics stock. Still, in general, we apply an absolute valuation method to find AptaBio Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of AptaBio Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against AptaBio Therapeutics' related companies.
 Open High Low Close Volume
  8,050    8,140    7,950    7,950    94,848  
09/26/2024
  7,980    8,220    7,980    8,150    82,484  
  8,220    8,220    7,840    7,900    105,979  
Backtest AptaBio Therapeutics  |  AptaBio Therapeutics History  |  AptaBio Therapeutics Valuation   PreviousNext  
Open Value
7980.0
8150.0
Closing Value
7,992
Upside

AptaBio Therapeutics Trading Date Momentum on September 26, 2024

On September 27 2024 AptaBio Therapeutics was traded for  7,900  at the closing time. The highest price during the trading period was 8,220  and the lowest recorded bid was listed for  7,840 . The volume for the day was 106 K. This history from September 27, 2024 contributed to the next trading day price decline. The daily price change to the next closing price was 3.07% . The overall trading delta to the current price is 6.13% .

AptaBio Therapeutics Fundamentals Correlations and Trends

By evaluating AptaBio Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among AptaBio Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. AptaBio financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About AptaBio Therapeutics Stock history

AptaBio Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for AptaBio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in AptaBio Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing AptaBio Therapeutics stock prices may prove useful in developing a viable investing in AptaBio Therapeutics

AptaBio Therapeutics Stock Technical Analysis

AptaBio Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of AptaBio Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of AptaBio Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

AptaBio Therapeutics Period Price Range

Low
November 26, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

AptaBio Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on KOSDAQ. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

AptaBio Therapeutics November 26, 2024 Market Strength

Market strength indicators help investors to evaluate how AptaBio Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AptaBio Therapeutics shares will generate the highest return on investment. By undertsting and applying AptaBio Therapeutics stock market strength indicators, traders can identify AptaBio Therapeutics entry and exit signals to maximize returns

AptaBio Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for AptaBio Therapeutics' price direction in advance. Along with the technical and fundamental analysis of AptaBio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of AptaBio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for AptaBio Stock analysis

When running AptaBio Therapeutics' price analysis, check to measure AptaBio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AptaBio Therapeutics is operating at the current time. Most of AptaBio Therapeutics' value examination focuses on studying past and present price action to predict the probability of AptaBio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AptaBio Therapeutics' price. Additionally, you may evaluate how the addition of AptaBio Therapeutics to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like